First rifapentine product prequalified
M
-
TB336: Rifapentine - 150mg - Film-coated tablets - Sanofi-Aventis U.S. LLC - USA
5th Invitation to Manufacturers of Medicinal Products for Treatment of Neglected Tropical Diseases
M
The following products were added:
-
Miltefosine 10mg and 50mg capsule
BTIF revised
M
The revisions to the BTIF (Bioequivalence Trial Information Form) include the following changes to facilitate study assessment:
12th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) for prequalification
M
The following active pharmaceutical ingredients (APIs) were added:
- Benzathine benzylpen
11th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs)
M
The 11th invitation to manufacturers of active pharmaceutical ingredients (APIs) to submit an expression of interest (EOI) for API prequalification to the WHO Prequalification Team: medicines (PQTm
EUL for IVDs – Bundibugyo virus (BDBV) nucleic acid detection
IVD
WHO has published detailed submission instructions for the Emergency Use Listing (EUL) of in vitro diagnostics for Bundibugyo virus disease (BDBV)
WHO's Public Assessment Reports (WHOPAR) Update 17 April to 27 May 2026
IVD
Between 17 April and 27 May 2026, several WHO Public Assessment Reports (WHOPARs) were updated to reflect changes in product labelling, documentation, and other relevant post-prequ